Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Iborra M, Caballol B, Garrido A, Huguet JM, et al. Subcutaneous infliximab cut-off points in patients with inflammatory bowel disease. Data from the ENEIDA registry. J Crohns Colitis 2024 Aug 22:jjae127. doi: 10.1093.
PMID: 39171615


Privacy Policy